Cargando…
Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscleinvasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette- Guérin (BCG): results of an international individual patient data survey (IPDS)
OBJECTIVES: To examine the management of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC), particularly with regard to the use of bacillus Calmette-Guérin (BCG) therapy, in North America and Europe. To compare NMIBC management practices to European Association of Urology (EAU)...
Autores principales: | Witjes, J Alfred, Palou, Joan, Soloway, Mark, Lamm, Donald, Kamat, Ashish M, Brausi, Maurizio, Persad, Raj, Buckley, Roger, Colombel, Marc, Böhle, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933735/ https://www.ncbi.nlm.nih.gov/pubmed/23452187 http://dx.doi.org/10.1111/bju.12012 |
Ejemplares similares
-
Systemic Bacillus Calmette-Guérin (BCG) Infection With Renal Involvement: A Rare Complication of BCG Immunotherapy
por: Afonso, Raquel, et al.
Publicado: (2022) -
The Management of Bacillus Calmette-Guérin (BCG) Failure in High-Risk Non-muscle Invasive Bladder Cancer: A Review Article
por: Kodera, Ahmed, et al.
Publicado: (2023) -
Outcomes of BCG Induction in High-Risk Non-Muscle-Invasive Bladder Cancer Patients (NMIBC): A Retrospective Cohort Study
por: Pirzada, Muhammad T, et al.
Publicado: (2017) -
Vertebral Osteomyelitis Secondary to Bacillus Calmette-Guérin Instillation Therapy for Transitional Cell Carcinoma In Situ
por: Jaber, Tariq M, et al.
Publicado: (2021) -
Lumbosacral Vertebral Osteomyelitis With Iliopsoas and Epidural Abscess Following Intravesical Bacillus Calmette-Guérin Therapy
por: Abbas, Anas M, et al.
Publicado: (2023)